Every source cited on this claim, counted once at its highest evidence strength and grouped by the side it supports. Generated from this page's own evidence rows — the same records the verdict is computed from — so the chart and the score cannot disagree. Strength labels follow the scoring methodology.

View figure at source: National Trends and Predictors of Waiting Times for Cancer Surgery in the US

The national temporal-trend figure from the JAMA Surgery study showing changes in U.S. cancer-surgery waiting times over the study period, likely stratified by cancer type and patient or hospital char

This is the most direct national evidence for the claim and should provide the clearest visual answer to whether cancer-surgery waits increased over time in the United States.

View figure at source: Wait times between lung cancer diagnosis and surgery: national trends, disparities, and impact on long-term survival

A longitudinal trend chart from the national lung-cancer study showing the interval between diagnosis and surgery across calendar years, with comparisons by race, insurance, geography, or hospital cha

It gives readers a concrete cancer-specific example of the broader national trend while showing that average waits can conceal substantial disparities in access.

Source: Impact of cancer surgery slowdowns on patient survival during the COVID-19 pandemic

The COVID-19 cancer-surgery slowdown figure modeling the relationship between surgical delay and reduced survival, typically displayed as survival curves or a plot of predicted survival by weeks of de

This figure supplies the essential consequence of waiting longer: it distinguishes the temporary pandemic disruption from the long-term trend and shows why changes in surgical timing matter clinically.

All contributions are reviewed for clarity, balance, and evidence. The strongest insights are elevated into the argument graph — with credit to you.

Help improve this analysis →

𝕏 Share Facebook LinkedIn